Immunomodulatory Mechanism and Potential Therapies for Perinatal Hypoxic-Ischemic Brain Damage

Overview

Journal Front Pharmacol

Date 2021 Feb 4

PMID 33536907

Citations 15

Authors

Ying-Jun Min

Eng-Ang Ling

Fan Li

Affiliations

Soon will be listed here.

Abstract

Hypoxia-ischemia (HI) is one of the most common causes of death and disability in neonates. Currently, the only available licensed treatment for perinatal HI is hypothermia. However, it alone is not sufficient to prevent the brain injuries and/or neurological dysfunction related to HI. Perinatal HI can activate the immune system and trigger the peripheral and central responses which involve the immune cell activation, increase in production of immune mediators and release of reactive oxygen species. There is mounting evidence indicating that regulation of immune response can effectively rescue the outcomes of brain injury in experimental perinatal HI models such as Rice-Vannucci model of newborn hypoxic-ischemic brain damage (HIBD), local transient cerebral ischemia and reperfusion model, perinatal asphyxia model, and intrauterine hypoxia model. This review summarizes the many studies about immunomodulatory mechanisms and therapies for HI. It highlights the important actions of some widely documented therapeutic agents for effective intervening of HI related brain damage, namely, HIBD, such as EPO, FTY720, Minocycline, Gastrodin, Breviscapine, Milkvetch etc. In this connection, it has been reported that the ameboid microglial cells featured prominently in the perinatal brain represent the key immune cells involved in HIBD. To this end, drugs, chemical agents and herbal compounds which have the properties to suppress microglia activation have recently been extensively explored and identified as potential therapeutic agents or strategies for amelioration of neonatal HIBD.

Citing Articles

Neuroinflammation mediates the progression of neonate hypoxia-ischemia brain damage to Alzheimer's disease: a bioinformatics and experimental study.

Zhang S, Zhang R, Chen Z, Shao Z, Li A, Li F Front Aging Neurosci. 2025; 16():1511668.

PMID: 39872979 PMC: 11770030. DOI: 10.3389/fnagi.2024.1511668.

The protective effects of gastrodin on neurological disorders: an update and future perspectives.

Shi Z, Zhang Y, Xiao Y, Shi Z, Wei X, Wang B Front Pharmacol. 2025; 15():1494277.

PMID: 39776583 PMC: 11703667. DOI: 10.3389/fphar.2024.1494277.

Altered sleep and inflammation are related to outcomes in neonatal encephalopathy.

Hurley T, Stewart P, McCarthy R, ODea M, Kelly L, Daly M Acta Paediatr. 2024; 114(2):428-436.

PMID: 39498720 PMC: 11706749. DOI: 10.1111/apa.17457.

Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets.

Nisar A, Khan S, Li W, Hu L, Samarawickrama P, Gold N MedComm (2020). 2024; 5(11):e786.

PMID: 39415849 PMC: 11480526. DOI: 10.1002/mco2.786.

Development and Optimization of Nasal Composition of a Neuroprotective Agent for Use in Neonatology after Prenatal Hypoxia.

Belenichev I, Aliyeva O, Burlaka B, Burlaka K, Kuchkovskyi O, Savchenko D Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204095 PMC: 11356968. DOI: 10.3390/ph17080990.

References

Kremlev S, Roberts R, Palmer C . Minocycline modulates chemokine receptors but not interleukin-10 mRNA expression in hypoxic-ischemic neonatal rat brain. J Neurosci Res. 2007; 85(11):2450-9. DOI: 10.1002/jnr.21380. View

Driscoll D, Felice V, Kenny L, Boylan G, OKeeffe G . Mild prenatal hypoxia-ischemia leads to social deficits and central and peripheral inflammation in exposed offspring. Brain Behav Immun. 2018; 69:418-427. DOI: 10.1016/j.bbi.2018.01.001. View

Papp L, Vizi E, Sperlagh B . Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/- mice. Neuroreport. 2005; 15(15):2387-91. DOI: 10.1097/00001756-200410250-00017. View

Xiao J, Huang Y, Li X, Li L, Yang T, Huang L . TNP-ATP is Beneficial for Treatment of Neonatal Hypoxia-Induced Hypomyelination and Cognitive Decline. Neurosci Bull. 2016; 32(1):99-107. PMC: 5563748. DOI: 10.1007/s12264-015-0003-8. View

Chan R, Chen W, Dong A, Guo D, Wong M . Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab. 2002; 87(8):3691-5. DOI: 10.1210/jcem.87.8.8717. View

Tu L, Wang Y, Chen D, Xiang P, Shen J, Li Y . Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic-Ischemic Brain Injury. Neurochem Res. 2018; 43(6):1210-1226. PMC: 5996020. DOI: 10.1007/s11064-018-2538-3. View

Gonzalez H, Hunter C, Bennet L, Power G, Gunn A . Cerebral oxygenation during postasphyxial seizures in near-term fetal sheep. J Cereb Blood Flow Metab. 2005; 25(7):911-8. DOI: 10.1038/sj.jcbfm.9600087. View

Liu F, Wang Y, Yao W, Xue Y, Zhou J, Liu Z . Geniposide attenuates neonatal mouse brain injury after hypoxic-ischemia involving the activation of PI3K/Akt signaling pathway. J Chem Neuroanat. 2019; 102:101687. DOI: 10.1016/j.jchemneu.2019.101687. View

Cao Q, Lu J, Kaur C, Sivakumar V, Li F, Cheah P . Expression of Notch-1 receptor and its ligands Jagged-1 and Delta-1 in amoeboid microglia in postnatal rat brain and murine BV-2 cells. Glia. 2008; 56(11):1224-37. DOI: 10.1002/glia.20692. View

10.

Yeh C, Yeh C, Yu T, Chang K, Huang C, Hsu K . Neonatal Dexamethasone Treatment Exacerbates Hypoxia/Ischemia-Induced White Matter Injury. Mol Neurobiol. 2016; 54(9):7083-7095. DOI: 10.1007/s12035-016-0241-4. View

11.

Lu W, Li G, Xie H, Qiu B, Yang R, Guo Z . Erythromycin pretreatment induces tolerance against focal cerebral ischemia through up-regulation of nNOS but not down-regulation of HIF-1α in rats. Neurol Sci. 2013; 35(5):687-93. DOI: 10.1007/s10072-013-1584-5. View

12.

Ikeda T, Mishima K, Aoo N, Liu A, Egashira N, Iwasaki K . Dexamethasone prevents long-lasting learning impairment following a combination of lipopolysaccharide and hypoxia-ischemia in neonatal rats. Am J Obstet Gynecol. 2005; 192(3):719-26. DOI: 10.1016/j.ajog.2004.12.048. View

13.

Hagberg H, Mallard C, Ferriero D, Vannucci S, Levison S, Vexler Z . The role of inflammation in perinatal brain injury. Nat Rev Neurol. 2015; 11(4):192-208. PMC: 4664161. DOI: 10.1038/nrneurol.2015.13. View

14.

Bertucci M, Loose J, Wallace E, Jenkin G, Miller S . Anti-inflammatory therapy in an ovine model of fetal hypoxia induced by single umbilical artery ligation. Reprod Fertil Dev. 2011; 23(2):346-52. DOI: 10.1071/RD10110. View

15.

Tsuji M, Wilson M, Lange M, Johnston M . Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol. 2004; 189(1):58-65. DOI: 10.1016/j.expneurol.2004.01.011. View

16.

Zhang Q, Ding Y, Yao Y, Yu Y, Yang L, Cui H . Creating rat model for hypoxic brain damage in neonates by oxygen deprivation. PLoS One. 2013; 8(12):e83589. PMC: 3866139. DOI: 10.1371/journal.pone.0083589. View

17.

Li Y, Yang Y, Zhao Y, Zhang J, Liu B, Jiao S . Astragaloside IV reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-II. Free Radic Biol Med. 2018; 131:251-263. DOI: 10.1016/j.freeradbiomed.2018.11.033. View

18.

Wang Q, Ye H, Su Y . Transcranial Doppler sonography monitors cerebral blood flow of mannitol-treated patients with acute large hemispheric infarction. Turk Neurosurg. 2014; 24(3):333-6. DOI: 10.5137/1019-5149.JTN.7727-12.1. View

19.

Augusto-Oliveira M, Arrifano G, Lopes-Araujo A, Santos-Sacramento L, Takeda P, Anthony D . What Do Microglia Really Do in Healthy Adult Brain?. Cells. 2019; 8(10). PMC: 6829860. DOI: 10.3390/cells8101293. View

20.

Nalivaeva N, Turner A, Zhuravin I . Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration. Front Neurosci. 2018; 12:825. PMC: 6254649. DOI: 10.3389/fnins.2018.00825. View